ConductScience.org, home

Trial · NCT02256475

Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome

NCT02256475, Phase 1, Completed, Neurocrine Biosciences

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome. Trials, record NCT02256475. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02256475

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
NCT number
NCT02256475
Status
Completed
Phases
Phase 1
Enrollment
36 participants, actual
Lead sponsor
Neurocrine Biosciences
Conditions
Tourette Syndrome
Interventions
NBI-98854
First posted
2014-10-03
Last updated
2016-01-07

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of participants with adverse events following dosing with NBI-98854Up to 21 days
PrimaryArea Under Curve (AUC) of NBI-98854 and its metabolites following repeated daily doses of NBI-98854Day 1: predose, 0.5, 1, 2, 4, 6, 8, 12, 24 hours post-dose; Day 14: predose, 0.5, 1, 2, 4, 6, 8, 12, 24, 72, 120, 168 hours postdose
PrimaryAssessment of tic behaviors associated with TS using the Yale Global Tic Severity Scale (YGTSS)Days 1, 7, 14, and 21
SecondaryAssessment of tic behaviors associated with TS using the Rush Video-based Tic Rating Scale (RTRS)Days 1, 7, 14, and 21
SecondaryQuantification of the premonitory urge phenomena associated with tics using the Premonitory Urge for Tics Scale (PUTS)Days 1, 7, 14, and 21
SecondaryClinical Global Impression of Tourette Syndrome (CGI-TS)Days 1, 7, 14, and 21
SecondaryCogState computerized test to assess cognitive functionDay 1 at predose, 2.5 and 8 hours postdose; Day 14 at 8 hours postdose

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02256475

GET https://conductscience.org/api/trials/v1/NCT02256475/registered